ACADIA Pharmaceuticals Inc. (ACAD) announced after the bell Wednesday that Uli Hacksell Ph.D., has retired as its Chief Executive Officer and as a member of the Board of Directors, effective today.
The company also announced that it has delayed its plans to submit its NUPLAZID NDA until the second half of 2015. The company had previously planned to submit the NDA in the first quarter of 2015. The stock is now down 8.98 on 2.1 million shares.
ACADIA Pharmaceuticals dipped in early trade Wednesday, before settling into a range. The stock pulled back slightly from the highs of the year and finished with a loss of 1.12 at $44.76.
For comments and feedback: editorial@rttnews.com